Sei Investments CO United Therapeutics Corp Transaction History

Sei Investments CO

  • $66.7 Billion
  • Q1 2024

A detailed history of Sei Investments CO transactions in United Therapeutics Corp stock. As of the latest transaction made, Sei Investments CO holds 37,257 shares of UTHR stock, worth $11.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
37,257
Previous 36,108 3.18%
Holding current value
$11.8 Million
Previous $7.94 Million 7.8%
% of portfolio
0.01%
Previous 0.01%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024
BUY
$210.76 - $249.51 $242,163 - $286,686
1,149 Added 3.18%
37,257 $8.56 Million
Q4 2023

Feb 14, 2024
BUY
$214.88 - $256.94 $1.1 Million - $1.32 Million
5,138 Added 16.59%
36,108 $7.94 Million
Q3 2023

Nov 14, 2023
BUY
$211.82 - $248.24 $751,537 - $880,755
3,548 Added 12.94%
30,970 $7 Million
Q2 2023

Aug 11, 2023
BUY
$205.19 - $232.99 $113,880 - $129,309
555 Added 2.07%
27,422 $6.05 Million
Q1 2023

May 12, 2023
BUY
$212.99 - $276.17 $693,069 - $898,657
3,254 Added 13.78%
26,867 $6.02 Million
Q4 2022

Feb 10, 2023
SELL
$205.95 - $280.43 $4.19 Million - $5.71 Million
-20,362 Reduced 46.3%
23,613 $6.57 Million
Q3 2022

Nov 14, 2022
SELL
$203.3 - $244.17 $4.79 Million - $5.76 Million
-23,581 Reduced 34.91%
43,975 $9.21 Million
Q2 2022

Aug 15, 2022
BUY
$174.81 - $241.14 $1.37 Million - $1.9 Million
7,863 Added 13.17%
67,556 $15.9 Million
Q1 2022

May 13, 2022
SELL
$166.16 - $213.96 $386,654 - $497,884
-2,327 Reduced 3.75%
59,693 $10.8 Million
Q4 2021

Feb 14, 2022
SELL
$184.32 - $216.08 $1.25 Million - $1.47 Million
-6,791 Reduced 9.87%
62,020 $13.5 Million
Q3 2021

Nov 12, 2021
BUY
$179.86 - $214.88 $2.11 Million - $2.52 Million
11,728 Added 20.55%
68,811 $12.8 Million
Q2 2021

Aug 06, 2021
SELL
$170.47 - $211.93 $313,664 - $389,951
-1,840 Reduced 3.12%
57,083 $10.2 Million
Q1 2021

May 12, 2021
BUY
$153.94 - $174.85 $100,676 - $114,351
654 Added 1.12%
58,923 $8.98 Million
Q4 2020

Feb 08, 2021
BUY
$101.87 - $151.79 $2.96 Million - $4.41 Million
29,086 Added 99.67%
58,269 $8.85 Million
Q3 2020

Dec 04, 2020
SELL
$99.9 - $121.13 $52,147 - $63,229
-522 Reduced 1.76%
29,183 $2.97 Million
Q3 2020

Nov 06, 2020
BUY
$99.9 - $121.13 $148,651 - $180,241
1,488 Added 5.27%
29,705 $3.02 Million
Q2 2020

Aug 17, 2020
BUY
$92.74 - $125.82 $103,034 - $139,786
1,111 Added 4.1%
28,217 $3.41 Million
Q2 2020

Aug 11, 2020
BUY
$92.74 - $125.82 $2.25 Million - $3.06 Million
24,286 Added 861.21%
27,106 $3.26 Million
Q1 2020

May 14, 2020
SELL
$79.39 - $115.35 $12,305 - $17,879
-155 Reduced 5.21%
2,820 $253,000
Q4 2019

Feb 06, 2020
SELL
$78.31 - $95.34 $16,836 - $20,498
-215 Reduced 6.74%
2,975 $255,000
Q3 2019

Nov 12, 2019
SELL
$74.85 - $85.99 $3,592 - $4,127
-48 Reduced 1.48%
3,190 $218,000
Q2 2019

Aug 14, 2019
SELL
$76.06 - $120.81 $705,380 - $1.12 Million
-9,274 Reduced 74.12%
3,238 $221,000
Q1 2019

May 15, 2019
BUY
$107.15 - $126.84 $76,826 - $90,944
717 Added 6.08%
12,512 $1.47 Million
Q4 2018

Feb 13, 2019
BUY
$101.4 - $128.73 $794,367 - $1.01 Million
7,834 Added 197.78%
11,795 $1.3 Million
Q3 2018

Nov 08, 2018
SELL
$113.81 - $129.46 $784,492 - $892,367
-6,893 Reduced 63.51%
3,961 $524,000
Q2 2018

Aug 03, 2018
BUY
$101.14 - $118.31 $119,749 - $140,079
1,184 Added 12.24%
10,854 $1.23 Million
Q1 2018

May 11, 2018
BUY
$107.21 - $151.94 $124,792 - $176,858
1,164 Added 13.68%
9,670 $1.09 Million
Q4 2017

Feb 08, 2018
BUY
$118.58 - $151.28 $59,408 - $75,791
501 Added 6.26%
8,506 $1.26 Million
Q3 2017

Nov 06, 2017
BUY
$114.6 - $136.81 $917,373 - $1.1 Million
8,005
8,005 $938,000

Others Institutions Holding UTHR

# of Institutions
561
Shares Held
43.1M
Call Options Held
501K
Put Options Held
529K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $14.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Sei Investments CO Portfolio

Follow Sei Investments CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

News

Stay updated on Sei Investments CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email